TEVA PHARMACEUTICALS USA, INC. — SPE2DP25F4433 — Federal Contract Award | GovChime

PIID: SPE2DP25F4433 • Signed: Mar 6, 2025AWARDDELIVERY ORDERSmall Business

8511229349!ADENOVIRUS TYPE 4 A

Total Obligated:$330,314

Overview

Total Obligated

$330,314

Potential Value

$330,314

Transactions

Contract Details

PIID:

SPE2DP25F4433

Award Type:

DELIVERY ORDER

Award/IDV:AWARD

Pricing Type:FIRM FIXED PRICE

Date Signed:Mar 6, 2025

Fiscal Year:2025

Period of Performance:Mar 6, 2025 - Mar 25, 2025

Potential End Date:Mar 24, 2025

Parent IDV PIID:SPE2DP20D0002

Multi-year Contract:NO

Performance-Based Service:NOT APPLICABLE

Financial Breakdown

Base + Exercised Options:$330,314

Base + All Options:$330,314

Description of Requirement

8511229349!ADENOVIRUS TYPE 4 A

Awardee Information

Name

UEINEN9A34LRHJ5

CAGE Code3V8D7

Business SizeOTHER THAN SMALL BUSINESS

Cong. DistrictPA-01

Address

1090 HORSHAM RD, NORTH WALES, PA, 194541505

Certifications

None listed

Parent Company

NameTEVA PHARMACEUTICALS USA, INC.

UEINEN9A34LRHJ5

Agency & Location

Contracting Agency

DepartmentDepartment of Defense

Sub-tier AgencyDefense Logistics Agency

Contracting OfficeDLA TROOP SUPPORT

Funding Agency

DepartmentDepartment of Defense

Sub-tier AgencyDefense Logistics Agency

Funding OfficeDLA TROOP SUPPORT

Place of Performance

PARSIPPANY, MORRIS, NEW JERSEY, 070541120, UNITED STATES

Congressional District: NJ-11

Classification & Competition

Classification Codes

NAICS Code

325412

PHARMACEUTICAL PREPARATION MANUFACTURING

PSC Code

6505

DRUGS AND BIOLOGICALS

Competition Information

Extent CompetedNOT COMPETED

Solicitation ProceduresONLY ONE SOURCE

Set-Aside Type

N/A

Number of OffersN/A

Transaction History

Mod #	Action Date	Obligation Change	Cumulative Total	Reason
0	Mar 6, 2025	+$330,314	$330,314	-